334 related articles for article (PubMed ID: 29183858)
21. Data-enriched edible pharmaceuticals (DEEP) of medical cannabis by inkjet printing.
Öblom H; Cornett C; Bøtker J; Frokjaer S; Hansen H; Rades T; Rantanen J; Genina N
Int J Pharm; 2020 Nov; 589():119866. PubMed ID: 32919002
[TBL] [Abstract][Full Text] [Related]
22. Social aspects in additive manufacturing of pharmaceutical products.
Lind J; Kälvemark Sporrong S; Kaae S; Rantanen J; Genina N
Expert Opin Drug Deliv; 2017 Aug; 14(8):927-936. PubMed ID: 27892721
[TBL] [Abstract][Full Text] [Related]
23. Continuous inkjet printing of enalapril maleate onto orodispersible film formulations.
Thabet Y; Lunter D; Breitkreutz J
Int J Pharm; 2018 Jul; 546(1-2):180-187. PubMed ID: 29753906
[TBL] [Abstract][Full Text] [Related]
24. Analysis of 3D Prints by X-ray Computed Microtomography and Terahertz Pulsed Imaging.
Markl D; Zeitler JA; Rasch C; Michaelsen MH; Müllertz A; Rantanen J; Rades T; Bøtker J
Pharm Res; 2017 May; 34(5):1037-1052. PubMed ID: 28004318
[TBL] [Abstract][Full Text] [Related]
25. Current Trends on Medical and Pharmaceutical Applications of Inkjet Printing Technology.
Scoutaris N; Ross S; Douroumis D
Pharm Res; 2016 Aug; 33(8):1799-816. PubMed ID: 27174300
[TBL] [Abstract][Full Text] [Related]
26. 3D Printing of Solid Oral Dosage Forms: Numerous Challenges With Unique Opportunities.
Okafor-Muo OL; Hassanin H; Kayyali R; ElShaer A
J Pharm Sci; 2020 Dec; 109(12):3535-3550. PubMed ID: 32976900
[TBL] [Abstract][Full Text] [Related]
27. Behavior of printable formulations of loperamide and caffeine on different substrates--effect of print density in inkjet printing.
Genina N; Fors D; Palo M; Peltonen J; Sandler N
Int J Pharm; 2013 Sep; 453(2):488-97. PubMed ID: 23769992
[TBL] [Abstract][Full Text] [Related]
28. Comparative investigations on key factors and print head designs for pharmaceutical inkjet printing.
Kiefer O; Breitkreutz J
Int J Pharm; 2020 Aug; 586():119561. PubMed ID: 32585176
[TBL] [Abstract][Full Text] [Related]
29. Pharmaceutical Additive Manufacturing: a Novel Tool for Complex and Personalized Drug Delivery Systems.
Zhang J; Vo AQ; Feng X; Bandari S; Repka MA
AAPS PharmSciTech; 2018 Nov; 19(8):3388-3402. PubMed ID: 29943281
[TBL] [Abstract][Full Text] [Related]
30. Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder.
Infanger S; Haemmerli A; Iliev S; Baier A; Stoyanov E; Quodbach J
Int J Pharm; 2019 Jan; 555():198-206. PubMed ID: 30458260
[TBL] [Abstract][Full Text] [Related]
31. The potential of three-dimensional printing for pediatric oral solid dosage forms.
Kreft K; Fanous M; Möckel V
Acta Pharm; 2024 Jun; 74(2):229-248. PubMed ID: 38815205
[TBL] [Abstract][Full Text] [Related]
32. 3D-Printed Drugs for Children-Are We Ready Yet?
Preis M; Öblom H
AAPS PharmSciTech; 2017 Feb; 18(2):303-308. PubMed ID: 28078628
[TBL] [Abstract][Full Text] [Related]
33. 3D printed drug delivery devices: perspectives and technical challenges.
Palo M; Holländer J; Suominen J; Yliruusi J; Sandler N
Expert Rev Med Devices; 2017 Sep; 14(9):685-696. PubMed ID: 28774216
[TBL] [Abstract][Full Text] [Related]
34. Dropwise additive manufacturing of pharmaceutical products for solvent-based dosage forms.
Hirshfield L; Giridhar A; Taylor LS; Harris MT; Reklaitis GV
J Pharm Sci; 2014 Feb; 103(2):496-506. PubMed ID: 24311373
[TBL] [Abstract][Full Text] [Related]
35. Overview of drug product development.
Narayan P
Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
[TBL] [Abstract][Full Text] [Related]
36. Printing technologies in fabrication of drug delivery systems.
Kolakovic R; Viitala T; Ihalainen P; Genina N; Peltonen J; Sandler N
Expert Opin Drug Deliv; 2013 Dec; 10(12):1711-23. PubMed ID: 24256326
[TBL] [Abstract][Full Text] [Related]
37. Dropwise additive manufacturing of pharmaceutical products for melt-based dosage forms.
Içten E; Giridhar A; Taylor LS; Nagy ZK; Reklaitis GV
J Pharm Sci; 2015 May; 104(5):1641-9. PubMed ID: 25639605
[TBL] [Abstract][Full Text] [Related]
38. Inkjet Printing of Drug-Loaded Mesoporous Silica Nanoparticles-A Platform for Drug Development.
Wickström H; Hilgert E; Nyman JO; Desai D; Şen Karaman D; de Beer T; Sandler N; Rosenholm JM
Molecules; 2017 Nov; 22(11):. PubMed ID: 29160839
[TBL] [Abstract][Full Text] [Related]
39. Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs.
Cheow WS; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():314-21. PubMed ID: 26325060
[TBL] [Abstract][Full Text] [Related]
40. A Snapshot of Current Updates and Future Prospects of 3D Printing in Medical and Pharmaceutical Science.
Agrawal R; Garg A; Deshmukh R
Curr Pharm Des; 2023; 29(8):604-619. PubMed ID: 36852810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
